Alex Zhavoronkov
United StatesCEOMale7.0Global Dominance: 0.02%Dr. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a biotechnology company that specializes in using artificial intelligence to accelerate drug discovery and development. Under his leadership, the company has pioneered the use of generative AI in pharmaceuticals, resulting in the creation of numerous potential drug candidates. His vision focuses on integrating advanced technologies to improve healthcare outcomes and the efficiency of scientific research.
Power14,276
Reach225,019
Country presence
Recent news mentions
Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine, discussed a drug being developed to treat a serious lung disease.
Common antibiotic cefepime tied to 94% higher death risk, study findsFox News·United States· 2026-09-16
United States· 2026-09-16
Dr. Alex Zhavoronkov, the founder and CEO of Insilico Medicine, stated that the humanoid robot will work alongside scientists.
Robot hình người làm việc trong phòng thí nghiệm thuốcVnExpress – leading Vietnamese online newspaper, est. 2001·
Vietnam· 2025-03-07
Vietnam· 2025-03-07
